title: Prostate Cancer, Version 1.2016.
abstract: The NCCN Guidelines for Prostate Cancer address staging and risk assessment after an initial diagnosis of prostate cancer and management options for localized, regional, and metastatic disease. Recommendations for disease monitoring, treatment of recurrent disease, and systemic therapy for metastatic castration-recurrent prostate cancer also are included. This article summarizes the NCCN Prostate Cancer Panel's most significant discussions for the 2016 update of the guidelines, which include refinement of risk stratification methods and new options for the treatment of men with high-risk and very-high-risk disease and progressive castration-naïve disease.
authors.affiliation: Roswell Park Cancer Institute
authors.forename: James L
authors.initials: JL
authors.lastname: Mohler
authors.affiliation: Duke Cancer Institute
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Armstrong
authors.affiliation: The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
authors.forename: Robert R
authors.initials: RR
authors.lastname: Bahnson
authors.affiliation: Dana-Farber/Brigham and Women’s Cancer Center
authors.forename: Anthony Victor
authors.initials: AV
authors.lastname: D'Amico
authors.affiliation: Mayo Clinic Cancer Center
authors.forename: Brian J
authors.initials: BJ
authors.lastname: Davis
authors.affiliation: Memorial Sloan Kettering Cancer Center
authors.forename: James A
authors.initials: JA
authors.lastname: Eastham
authors.affiliation: Fred & Pamela Buffett Cancer Center
authors.forename: Charles A
authors.initials: CA
authors.lastname: Enke
authors.affiliation: Prostate Health Education Network (PHEN)
authors.forename: Thomas A
authors.initials: TA
authors.lastname: Farrington
authors.affiliation: Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance
authors.forename: Celestia S
authors.initials: CS
authors.lastname: Higano
authors.affiliation: Fox Chase Cancer Center
authors.forename: Eric M
authors.initials: EM
authors.lastname: Horwitz
authors.affiliation: Yale Cancer Center/Smilow Cancer Hospital
authors.forename: Michael
authors.initials: M
authors.lastname: Hurwitz
authors.affiliation: UC San Diego Moores Cancer Center
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: Kane
authors.affiliation: City of Hope Comprehensive Cancer Center
authors.forename: Mark H
authors.initials: MH
authors.lastname: Kawachi
authors.affiliation: Roswell Park Cancer Institute
authors.forename: Michael
authors.initials: M
authors.lastname: Kuettel
authors.affiliation: Massachusetts General Hospital Cancer Center
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Lee
authors.affiliation: Robert H. Lurie Comprehensive Cancer Center of Northwestern University
authors.forename: Joshua J
authors.initials: JJ
authors.lastname: Meeks
authors.affiliation: Vanderbilt-Ingram Cancer Center
authors.forename: David F
authors.initials: DF
authors.lastname: Penson
authors.affiliation: Moffitt Cancer Center
authors.forename: Elizabeth R
authors.initials: ER
authors.lastname: Plimack
authors.affiliation: University of Colorado Cancer Center
authors.forename: Julio M
authors.initials: JM
authors.lastname: Pow-Sang
authors.affiliation: St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center
authors.forename: David
authors.initials: D
authors.lastname: Raben
authors.affiliation: UCSF Helen Diller Family Comprehensive Cancer Center
authors.forename: Sylvia
authors.initials: S
authors.lastname: Richey
authors.affiliation: University of California San Francisco Patient Services Committee Chair
authors.forename: Mack
authors.initials: M
authors.lastname: Roach
authors.affiliation: The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
authors.forename: Stan
authors.initials: S
authors.lastname: Rosenfeld
authors.affiliation: University of Michigan Comprehensive Cancer Center
authors.forename: Edward
authors.initials: E
authors.lastname: Schaeffer
authors.affiliation: UCSF Helen Diller Family Comprehensive Cancer Center
authors.forename: Ted A
authors.initials: TA
authors.lastname: Skolarus
authors.affiliation: University of Alabama at Birmingham Comprehensive Cancer Center
authors.forename: Eric J
authors.initials: EJ
authors.lastname: Small
authors.affiliation: Stanford Cancer Institute
authors.forename: Guru
authors.initials: G
authors.lastname: Sonpavde
authors.affiliation: Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
authors.forename: Sandy
authors.initials: S
authors.lastname: Srinivas
authors.affiliation: Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
authors.forename: Seth A
authors.initials: SA
authors.lastname: Strope
authors.affiliation: Huntsman Cancer Institute at the University of Utah
authors.forename: Jonathan
authors.initials: J
authors.lastname: Tward
authors.affiliation: National Comprehensive Cancer Network
authors.forename: Dorothy A
authors.initials: DA
authors.lastname: Shead
authors.affiliation: National Comprehensive Cancer Network
authors.forename: Deborah A
authors.initials: DA
authors.lastname: Freedman-Cass
mesh_terms: D018450:Disease Progression; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D009919:Orchiectomy; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*